Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Plus Lofexidine for Outpatient Opioid Withdrawal
NCT05995535Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jan 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in opioid withdrawal syndrome (OWS), opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jan 2024; status: recruiting.
02
Drugs
pregabalin
03
Conditions
opioid withdrawal syndrome (OWS)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05995535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995535.